Pharmaceutical Stocks
Recent market-moving SEC filings and news across pharmaceutical companies, ranked by Wiseek's 1–10 importance score.
How Wiseek curates this list
Every item here is a high-importance (score ≥ 7) SEC filing or licensed news event for a pharmaceutical company, sourced from SEC EDGAR and licensed news wires and ranked by Wiseek's 1–10 importance score. The underlying source is linked from each article. See our methodology and editorial policy.
Related Healthcare industries
Biotech StocksMedical Device StocksHealth Tech StocksDiagnostics & Research StocksMedical Instrument StocksHealthcare Facility Stocks
See the full Healthcare sector feed.
ZeroStack Registers 54.6M Shares for Resale, Including 36.2M from MemeCore Deal
FTC Challenges Amgen's Patent Play in Enbrel Antitrust Case
Iheezo Cuts Eye-Injection Discomfort 58% in Head-to-Head Study
Alvotech Inks $150M Licensing Deal with Lotus for Two Biosimilars
Alvotech Inks $150M Licensing Deal with Lotus for Two Biosimilars
CEO Sean Brynjelsen Sells $6.1M in Eton Stock Over Two Days
Organigram Locks In Sanity Earnout at 85%, Unveils New Global Leadership
Alvotech Guides FY26 Revenue to $650M-$700M, Above Consensus
Alvotech Reports H1 Loss, Secures $239.6M Capital, and Receives Positive FDA Facility Outcome
KALA BIO's Q2 10-Q Reveals Material Weakness, $7M Loan, and AI Platform License
Aurora Cannabis Buys UK Distributor and Pharmacy for £2.1M
ZeroStack Buys $1B in MemeCore Tokens at 12x Premium, Appoints New President
Sunshine Biopharma Wins Canadian Approval for Enalapril, Shipping by Year-End
Aurora Cannabis Urges Shareholders to Take No Action on Curaleaf's Hostile Bid
Merck-Moderna mRNA Cancer Therapy Hits Phase 3 Endpoints in Melanoma
IM Cannabis Plans 30:1 Reverse Split to Avoid Nasdaq Delisting
ZeroStack Completes Texas Continuance, Adopts New Charter with 1T Authorized Shares
Nasdaq Extends Akanda's Deadline to December 13 for Equity Compliance
IM Cannabis Signs Definitive Agreement to Sell European Assets to CEO-Controlled Entity
J&J's Monarch Quest 3 Robotic Bronchoscopy Platform Cleared by FDA
Enhertu Hits Primary Endpoint in First-Line HER2-Mutant Lung Cancer
AstraZeneca Halts Phase III eVOLVE-Lung02 Trial of Volrustomig in Metastatic NSCLC
Tagrisso + Orpathys Hits Both PFS and OS Endpoints in Phase III SAFFRON Trial
Third FDA Form 483 in Two Months Hits Dr. Reddy's
IM Cannabis Signs Definitive Deal to Sell European Assets, Boosting Equity by C$3M
ORPATHYS plus TAGRISSO hits both PFS and OS endpoints in global Phase III SAFFRON trial
Citius Oncology Files Prospectus Supplement: Board Expansion, Q3 Losses, Going Concern Warning
Scilex Posts $115M Q2 Loss, Cash Dwindles to $0.6M, Going Concern Doubt Reiterated
Citius Oncology's Q3 Loss, Going Concern Warning, and Nasdaq Delisting Risk
Citius Oncology Q3 FY2026: $7.1M Revenue, 44 Institutions Ordering LYMPHIR
FDA Approves Lantheus Brain-Imaging Agent for Alzheimer's Assessment
Q2 2026 Results Extend Cash Runway to October 2027 as FDA Clears Lucid-MS Phase 2
Quantum BioPharma Cuts Cash Burn 44%, Extends Runway to October 2027
Oaktree Exits 5%+ Stake in Indivior, Sells 6.5M Shares
IM Cannabis Posts C$0.47 Q2 Loss Per Share Amid Going Concern Doubts
FDA Approves Bristol Myers' Iberdomide Combo for Multiple Myeloma
IM Cannabis Q2 Loss Widens to C$4.4M; Going Concern Doubts and Nasdaq Delisting Risk
Biofrontera Q2 Revenue Jumps 33% but Going Concern Warning and ITC Setback Cloud Outlook
Petros Pharmaceuticals Flags Going Concern, Material Weakness, and Massive Warrant Dilution
Shuttle Pharma Sets Sept 3 Vote on 17.6M Share Issuance, 8M Equity Plan Increase, and Name Change to United Compute